GL-ONC1
id:
gl-onc1-199-11972186
title:
GL-ONC1
text:
GL-ONC1 is an investigational therapeutic product consisting of the clinical grade formulation of the laboratory strain GLV-1h68, an oncolytic virus developed by Genelux Corporation. GL-ONC1 is currently under evaluation in Phase I/II human clinical trials in the United States and Europe. GL-ONC1 is a triple modified and attenuated vaccinia virus that causes regression and elimination of a wide range of solid tumors in preclinical mouse models. It was generated by insertion of three expression c
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/GL-ONC1
date created:
date modified:
2023-02-04T14:20:01Z
main entity:
{"identifier":"Q25326574","url":"https://www.wikidata.org/entity/Q25326574"}
image:
fields total:
13
integrity:
13